Medicure (CVE:MPH) Stock Passes Below 50 Day Moving Average of $1.16

Shares of Medicure Inc. (CVE:MPHGet Rating) crossed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$1.16 and traded as low as C$1.11. Medicure shares last traded at C$1.11, with a volume of 4,100 shares trading hands.

Medicure Stock Up 11.0 %

The firm has a market capitalization of C$11.38 million, a PE ratio of 8.54 and a beta of 1.09. The company has a quick ratio of 1.29, a current ratio of 1.77 and a debt-to-equity ratio of 4.04. The firm’s 50 day moving average price is C$1.16 and its two-hundred day moving average price is C$1.14.

Medicure (CVE:MPHGet Rating) last announced its earnings results on Thursday, April 6th. The company reported C$0.04 earnings per share for the quarter. Medicure had a return on equity of 6.93% and a net margin of 5.92%. The company had revenue of C$6.32 million during the quarter. As a group, research analysts forecast that Medicure Inc. will post 0.074184 EPS for the current fiscal year.

Medicure Company Profile

(Get Rating)

Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.

Read More

Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with's FREE daily email newsletter.